Across rheumatic diseases

Use of Biologics During Pregnancy Among Patients With Autoimmune Conditions

JAMA Netw OpenPublished Retrospective cohort study

Authors' conclusion

In this cohort study, a decline in the use of biologics for autoimmune disease was observed during the pregnancy period that rebounded only partially thereafter.

Study context

Population
Commercially insured pregnant patients aged 16 to 55 years with an autoimmune condition and biologic use 6 months before conception, US MarketScan, 2011–2022median age 32 years
Participants
6,131 participants
Exposure
Biologic use during pregnancy across autoimmune conditions
  • Crohn diseasen = 1,372
  • RAn = 1,295reference
Outcome
Proportion of patients using biologics during pregnancy; association between underlying autoimmune disease and biologic use
Methodological detailsadministrative claims database, multivariable logistic regression
  • Administrative claims database
  • Multivariable logistic regression

Main finding

As reported in the abstract

Biologic use at least once during pregnancy

All patients

4393

71.6%; 95% CI, 70.5%–72.8%

Observational data: associations, not effects.

Further findings

OutcomeOR (95% CI)
Biologic use during pregnancy by autoimmune conditionCrohn diseasevs RAMultivariable logistic regression7.88 (5.93–10.47)
Biologic use during pregnancy by autoimmune conditionUlcerative colitisvs RAMultivariable logistic regression5.35 (3.73–7.66)
Biologic use during pregnancy by autoimmune conditionPsoriasis or PsAvs RAMultivariable logistic regression0.65 (0.52–0.80)

Biologic use by trimester, pregnancies with live birth

First trimester
2981 (68.6% [95% CI, 67.2%-70.0%])
Second trimester
2555 (58.8% [95% CI, 57.3%-60.3%])
Third trimester
2113 (48.6% [95% CI, 47.1%-50.1%])
Post partum
3350 (77.1% [95% CI, 75.8%-78.3%])

Original publication

Use of Biologics During Pregnancy Among Patients With Autoimmune Conditions. JAMA Netw Open. Published 1 May 2025. doi:10.1001/jamanetworkopen.2025.10504

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.